Primary Cells
with a human relevant advantage
End-to-end in vitro offerings with peer-to- peer support
Quality that better represents human biology
We source our samples directly, and our expertise in the recovery and preservation of human tissues and cells, combined with our global logistical infrastructure, makes us uniquely capable of recapitulating human biology in vitro.
As a result, our cells, tissues, and the assays and services that incorporate them exhibit higher viability and repeatability, can include donor-matched samples, and come with full donor characterization.
New technologies that better capture human complexity
TruVivo® 2D+
Hepatic System
The simplicity of a 2D model, the robustness of a 3D model
Available as a kit or service
Human dynamic multi-organ
MPS platform
Up to three organ systems at a time with simulated blood flow
Available as a service
Human 3D thyroid
microtissue model
The first and only hormone-competent in vitro thyroid system
Available as a kit or service
Providing a holistic approach to discovery, toxicology, and beyond
Don’t see what you’re looking for? We also offer extensive custom solutions. Let us help you design your project or source custom samples.

Partner with the scientists
leading the in vitro
transition
As a non-profit, our primary mission is advancing your research. Our experts and our clients come for the science and stay for the partnerships.
Our clients include 19 out of the top 20 global pharmaceutical companies, and global leaders in translational research, agrochemicals, and cosmetics.
“The more the cells are characterized, the more technical and scientific support we need to successfully select the candidates for our applications. LifeNet Health provides a unique customer support, and possible access to world-renowned R&D scientists whenever we need help.”
Latest news
LifeNet Health Achieves ISO 9001:2015 Certification, Advancing High-Quality Research That Expands Access to Healthcare Innovation
ISO 9001:2015 Quality Management System (QMS) certification
Feb 4 2026
Inotiv, Inc. to leverage TruVivo® 2D+ hepatic system within its Discovery and Translational Sciences business to accelerate development of safer, more effective therapies through human-relevant science
Strengthened Partnership with Inotiv, Inc.
Jan 13 2026
LifeNet Health Selected by the Henry M. Jackson Foundation to Recover Biospecimens to Study the Effects of CTE in Military Personnel
The largest Department of Defense-funded CTE scientific research project at USUHS, this study aims to advance treatment options for U.S. service members over a five-year period
Apr 19 2024



























